DRDO’s 2-DG

Le traitement DRDO’s 2-DG a été approuvé en mai 2021 en Inde :

Easy to produce, easier to consume: DRDO’s 2-DG drug for treatment of Covid patients
The DCGI has granted emergency use approval to DRDO’s 2-DG drug for treatment in moderate to severe cases of Covid-19. Here are answers to all your questions about the drug. India Today

The Defence Research and Development Organisation (DRDO) on Tuesday said its anti-Covid drug, 2-deoxy-D-glucose or 2-DG, can be given to patients under the care and prescription of doctors as it issued directions for its use.
Hindustan Times

%d blogueurs aiment cette page :